1.
Maul J-T, Ak M, Cerminara SE, Steinmann S, Goessinger EV, Darzina A, et al. Tildrakizumab Treatment for Psoriasis in Real-world Practice: An Analysis from the Swiss Registry (SDNTT). Acta Derm Venereol [Internet]. 2024 Nov. 27 [cited 2025 Feb. 12];104:adv40946. Available from: https://medicaljournalssweden.se/actadv/article/view/40946